ICU Medical Quick Ratio 2010-2025 | ICUI
Historical quick ratio values for ICU Medical (ICUI) over the last 10 years.
| ICU Medical Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $0.83B | $0.55B | 1.52 |
| 2024-12-31 | $0.86B | $0.56B | 1.54 |
| 2024-09-30 | $0.57B | $0.55B | 1.03 |
| 2024-06-30 | $0.55B | $0.51B | 1.08 |
| 2024-03-31 | $0.50B | $0.46B | 1.09 |
| 2023-12-31 | $0.51B | $0.48B | 1.06 |
| 2023-09-30 | $0.46B | $0.46B | 0.99 |
| 2023-06-30 | $0.47B | $0.48B | 0.97 |
| 2023-03-31 | $0.47B | $0.46B | 1.01 |
| 2022-12-31 | $0.54B | $0.50B | 1.09 |
| 2022-09-30 | $0.57B | $0.49B | 1.17 |
| 2022-06-30 | $0.61B | $0.49B | 1.25 |
| 2022-03-31 | $0.64B | $0.49B | 1.29 |
| 2021-12-31 | $0.74B | $0.20B | 3.68 |
| 2021-09-30 | $0.72B | $0.19B | 3.89 |
| 2021-06-30 | $0.67B | $0.18B | 3.67 |
| 2021-03-31 | $0.63B | $0.18B | 3.49 |
| 2020-12-31 | $0.61B | $0.20B | 3.10 |
| 2020-09-30 | $0.58B | $0.19B | 3.12 |
| 2020-06-30 | $0.71B | $0.36B | 1.99 |
| 2020-03-31 | $0.69B | $0.36B | 1.93 |
| 2019-12-31 | $0.55B | $0.25B | 2.19 |
| 2019-09-30 | $0.60B | $0.26B | 2.35 |
| 2019-06-30 | $0.60B | $0.26B | 2.31 |
| 2019-03-31 | $0.60B | $0.24B | 2.51 |
| 2018-12-31 | $0.62B | $0.25B | 2.47 |
| 2018-09-30 | $0.62B | $0.20B | 3.07 |
| 2018-06-30 | $0.61B | $0.20B | 3.02 |
| 2018-03-31 | $0.57B | $0.20B | 2.88 |
| 2017-12-31 | $0.58B | $0.21B | 2.74 |
| 2017-09-30 | $0.59B | $0.20B | 3.01 |
| 2017-06-30 | $0.50B | $0.19B | 2.66 |
| 2017-03-31 | $0.44B | $0.16B | 2.74 |
| 2016-12-31 | $0.52B | $0.04B | 12.82 |
| 2016-09-30 | $0.45B | $0.03B | 13.90 |
| 2016-06-30 | $0.49B | $0.04B | 11.95 |
| 2016-03-31 | $0.47B | $0.03B | 13.71 |
| 2015-12-31 | $0.46B | $0.04B | 10.83 |
| 2015-09-30 | $0.47B | $0.04B | 12.71 |
| 2015-06-30 | $0.43B | $0.03B | 15.09 |
| 2015-03-31 | $0.42B | $0.03B | 12.66 |
| 2014-12-31 | $0.40B | $0.03B | 13.77 |
| 2014-09-30 | $0.39B | $0.03B | 13.21 |
| 2014-06-30 | $0.38B | $0.03B | 13.82 |
| 2014-03-31 | $0.36B | $0.03B | 14.28 |
| 2013-12-31 | $0.36B | $0.03B | 13.38 |
| 2013-09-30 | $0.33B | $0.03B | 12.18 |
| 2013-06-30 | $0.31B | $0.03B | 11.06 |
| 2013-03-31 | $0.30B | $0.03B | 11.64 |
| 2012-12-31 | $0.29B | $0.03B | 9.93 |
| 2012-09-30 | $0.28B | $0.03B | 9.51 |
| 2012-06-30 | $0.26B | $0.03B | 8.61 |
| 2012-03-31 | $0.24B | $0.03B | 9.40 |
| 2011-12-31 | $0.22B | $0.03B | 7.51 |
| 2011-09-30 | $0.19B | $0.02B | 8.05 |
| 2011-06-30 | $0.19B | $0.03B | 7.08 |
| 2011-03-31 | $0.17B | $0.03B | 6.22 |
| 2010-12-31 | $0.16B | $0.03B | 6.26 |
| 2010-09-30 | $0.15B | $0.03B | 5.70 |
| 2010-06-30 | $0.14B | $0.03B | 4.57 |
| 2010-03-31 | $0.14B | $0.03B | 4.65 |
| 2009-12-31 | $0.17B | $0.03B | 4.95 |
| 2009-09-30 | $0.17B | $0.02B | 7.05 |
| 2009-06-30 | $0.18B | $0.02B | 8.72 |
| 2009-03-31 | $0.17B | $0.02B | 7.42 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.378B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.442B | 27.95 |
| Boston Scientific (BSX) | United States | $153.655B | 38.47 |
| Stryker (SYK) | United States | $150.679B | 31.51 |
| EssilorLuxottica (ESLOY) | France | $135.238B | 0.00 |
| Medtronic (MDT) | Ireland | $114.659B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.418B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.416B | 25.92 |
| ResMed (RMD) | United States | $37.840B | 28.42 |
| Agilent Technologies (A) | United States | $35.272B | 22.99 |
| GE HealthCare Technologies (GEHC) | United States | $35.028B | 16.63 |
| Terumo (TRUMY) | Japan | $24.711B | 32.10 |
| Koninklijke Philips (PHG) | Netherlands | $23.746B | 16.66 |
| Insulet (PODD) | United States | $20.930B | 82.15 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.825B | 12.09 |
| Baxter (BAX) | United States | $15.241B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.608B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.072B | 24.61 |
| Lantheus Holdings (LNTH) | United States | $5.800B | 14.63 |
| Prestige Consumer Healthcare (PBH) | United States | $3.832B | 17.12 |
| Haemonetics (HAE) | United States | $3.755B | 17.10 |
| Perrigo (PRGO) | Ireland | $3.749B | 9.50 |
| Envista Holdings (NVST) | United States | $3.512B | 29.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.134B | 14.67 |
| LeMaitre Vascular (LMAT) | United States | $1.937B | 43.31 |
| AtriCure (ATRC) | United States | $1.587B | 0.00 |
| Acuren (TIC) | United States | $1.427B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.357B | 30.52 |
| AdaptHealth (AHCO) | United States | $1.275B | 12.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Neogen (NEOG) | United States | $1.211B | 15.50 |
| BioLife Solutions (BLFS) | United States | $1.087B | 0.00 |
| InMode (INMD) | Israel | $0.960B | 9.67 |
| Curaleaf Holdings (CURLF) | Canada | $0.818B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.780B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.736B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.641B | 0.00 |
| Owens & Minor (OMI) | United States | $0.640B | 5.31 |
| Evolus (EOLS) | United States | $0.627B | 0.00 |
| CeriBell (CBLL) | United States | $0.606B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.511B | 0.00 |
| Surmodics (SRDX) | United States | $0.444B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| Cresco Labs (CRLBF) | United States | $0.342B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.307B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Cerus (CERS) | United States | $0.296B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 78.17 |
| ZimVie (ZIMV) | United States | $0.262B | 11.90 |
| Brainsway (BWAY) | Israel | $0.239B | 63.17 |
| Biote (BTMD) | United States | $0.230B | 6.48 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Omeros (OMER) | United States | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.14 |
| Vireo Growth (VREOF) | United States | $0.164B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.25 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.91 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.57 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |